PLRZ
Polyrizon Ltd. Ordinary Shares
NASDAQ: PLRZ · HEALTHCARE · BIOTECHNOLOGY
$16.12
-4.90% today
Updated 2026-06-04
Market cap
$27.97M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.90
Dividend yield
—
52W range
$3 – $18
Volume
0.0M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C7.3
Quality
B+3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
27.6
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →205 stocks currently score above 75
Price targets
Analyst target
—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
Stock snapshot
Strengths
+ Altman Z 27.62 — safe zone
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-2.71M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Net income | $-779000.00 | $-600000.00 | $-1.54M | $-3.33M | $-3.16M |
| EPS | — | — | — | — | $-4.90 |
| Free cash flow | $-1.14M | $-537000.00 | $-1.15M | $-4.54M | $-2.71M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Polyrizon Ltd. Ordinary Shares trades at $16.12. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 27.62, it sits in the safe zone.
Frequently asked questions
What is Polyrizon Ltd. Ordinary Shares's stock price?
Polyrizon Ltd. Ordinary Shares (PLRZ) trades at $16.12.
Is Polyrizon Ltd. Ordinary Shares overvalued?
Polyrizon Ltd. Ordinary Shares carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
Altman Z-Score?
Polyrizon Ltd. Ordinary Shares's Altman Z-Score is 27.62, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-19.60%
Beta—
50D MA$13.79
200D MA$10.82
Shares out0.00B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—